Soiken Holdings Inc. (TYO:2385)

Japan flag Japan · Delayed Price · Currency is JPY
241.00
+3.00 (1.26%)
At close: Mar 27, 2026
Market Cap6.30B +74.6%
Revenue (ttm)4.58B -8.4%
Net Income173.00M
EPS6.61
Shares Out26.16M
PE Ratio36.44
Forward PEn/a
Dividend5.00 (2.07%)
Ex-Dividend DateJun 29, 2026
Volume48,800
Average Volume129,335
Open238.00
Previous Close238.00
Day's Range238.00 - 242.00
52-Week Range116.00 - 325.00
Beta-0.09
RSI46.33
Earnings DateMay 13, 2026

About Soiken Holdings

Soiken Holdings Inc. engages in the development of biomarkers in Japan. It is involved in the development and sale of cosmetics and dietary supplements comprising imidapeptides; licensing and development of biomarker technology; provision of marketing research and post-marketing surveys for dietary supplements; and research, development, and sale of functional materials, such as lactoferrin, as well as pharmaceutical products from ascochlorin derivatives. The company also provides clinical evaluation tests for foodstuffs using biomarker technol... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1994
Employees 81
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 2385
Full Company Profile

Financial Performance

In fiscal year 2025, Soiken Holdings's revenue was 4.85 billion, a decrease of -6.01% compared to the previous year's 5.16 billion. Losses were -210.00 million, -68.28% less than in 2024.

Financial Statements